As the population of cancer survivors has increased and continues to age, the occurrence of
second cancers has risen dramatically-from 9% of all cancer diagnoses in 1975-1979 to …

Background Estimation of the risk of adverse long‐term outcomes such as second malignant
neoplasms and infertility often requires reproducible quantification of exposures. The …

With improved outcomes associated with radiotherapy, radiation-induced sarcomas (RIS)
are increasingly seen in long-term survivors of head and neck cancers, with an estimated …

Osteosarcoma is the most common primary osseous malignancy excluding malignant
neoplasms of marrow origin (myeloma, lymphoma and leukemia) and accounts for …

BACKGROUND The leading cause of death among patients with hereditary retinoblastoma
is second malignancy. Despite its high rate of efficacy, radiotherapy (RT) is often avoided …

Purpose Hereditary retinoblastoma (Rb) survivors have increased risk of subsequent
malignant neoplasms (SMNs). Previous studies reported elevated radiotherapy (RT)-related …

Abstract Currently, 17–19% of all new primary malignancies occur in survivors of cancer,
causing substantial morbidity and mortality. Research has shown that cancer treatments are …

Background context Magnetically-controlled growing rod (MCGR) technology has been
reported for the treatment of early-onset scoliosis (EOS). Such technology allows for regular …

Bone sarcoma as a second malignancy is rare but highly fatal. The present knowledge
about radiation-absorbed organ dose–response is insufficient to predict the risks induced by …

Second malignant neoplasms (SMNs) and cardiovascular disease (CVD) are among the
most serious and life-threatening late adverse effects experienced by the growing number of …